MAOB and Parkinson disease: The treatment cohorts were generally comparable after matching with regard to age at PD diagnosis, gender, average disease duration, Charlson comorbidity score, GP consultations in 12 months prior to treatment initiation and other anti‐Parkinson's drugs (MAO‐B inhibitors, amantadine, apomorphine, Catechol‐O‐methyl transferase [COMT] or decarboxylase inhibitors) prior to treatment initiation.